Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Activation induced deaminase: how much and where?

Orthwein A, Di Noia JM.

Semin Immunol. 2012 Aug;24(4):246-54. doi: 10.1016/j.smim.2012.05.001. Epub 2012 Jun 9. Review.

PMID:
22687198
2.

Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.

Wakae K, Magor BG, Saunders H, Nagaoka H, Kawamura A, Kinoshita K, Honjo T, Muramatsu M.

Int Immunol. 2006 Jan;18(1):41-7. Epub 2005 Nov 15.

PMID:
16291656
3.

Activation-induced deaminase: light and dark sides.

de Yébenes VG, Ramiro AR.

Trends Mol Med. 2006 Sep;12(9):432-9. Epub 2006 Jul 24. Review.

PMID:
16861038
4.

Separate domains of AID are required for somatic hypermutation and class-switch recombination.

Shinkura R, Ito S, Begum NA, Nagaoka H, Muramatsu M, Kinoshita K, Sakakibara Y, Hijikata H, Honjo T.

Nat Immunol. 2004 Jul;5(7):707-12. Epub 2004 Jun 13.

PMID:
15195091
5.

Negative regulation of activation-induced cytidine deaminase in B cells.

Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2752-7. Epub 2006 Feb 13.

6.

Oncogenic events triggered by AID, the adverse effect of antibody diversification.

Pérez-Durán P, de Yebenes VG, Ramiro AR.

Carcinogenesis. 2007 Dec;28(12):2427-33. Epub 2007 Sep 4. Review.

PMID:
17804422
8.

DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.

Hackney JA, Misaghi S, Senger K, Garris C, Sun Y, Lorenzo MN, Zarrin AA.

Adv Immunol. 2009;101:163-89. doi: 10.1016/S0065-2776(08)01005-5. Review.

PMID:
19231595
9.

Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease.

Hase K, Takahashi D, Ebisawa M, Kawano S, Itoh K, Ohno H.

PLoS One. 2008 Aug 21;3(8):e3033. doi: 10.1371/journal.pone.0003033.

10.

The biochemistry of activation-induced deaminase and its physiological functions.

Larijani M, Martin A.

Semin Immunol. 2012 Aug;24(4):255-63. doi: 10.1016/j.smim.2012.05.003. Epub 2012 Jun 12. Review.

PMID:
22695318
11.
12.

A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.

Kotani A, Okazaki IM, Muramatsu M, Kinoshita K, Begum NA, Nakajima T, Saito H, Honjo T.

Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4506-11. Epub 2005 Mar 14.

13.

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.

Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, Janda J, Marcu KB, Parwaresch R.

Blood. 2003 May 1;101(9):3574-80. Epub 2003 Jan 2.

14.
15.

AID expression during B-cell development: searching for answers.

Kuraoka M, McWilliams L, Kelsoe G.

Immunol Res. 2011 Apr;49(1-3):3-13. doi: 10.1007/s12026-010-8185-7.

PMID:
21136202
16.
17.

The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.

Basu U, Chaudhuri J, Alpert C, Dutt S, Ranganath S, Li G, Schrum JP, Manis JP, Alt FW.

Nature. 2005 Nov 24;438(7067):508-11. Epub 2005 Oct 26.

PMID:
16251902
18.

Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation.

Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle-Brogard B, Pritsch O, Dighiero G.

Blood. 2003 May 15;101(10):4029-32. Epub 2003 Jan 9.

19.

Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation.

McBride KM, Gazumyan A, Woo EM, Barreto VM, Robbiani DF, Chait BT, Nussenzweig MC.

Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8798-803. Epub 2006 May 24.

20.

Structural phylogenetic analysis of activation-induced deaminase function.

Ichikawa HT, Sowden MP, Torelli AT, Bachl J, Huang P, Dance GS, Marr SH, Robert J, Wedekind JE, Smith HC, Bottaro A.

J Immunol. 2006 Jul 1;177(1):355-61.

Supplemental Content

Support Center